Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Biodegradable polydioxanone stents in the treatment of adult patients with tracheal narrowing

L. Stehlik, V. Hytych, J. Letackova, P. Kubena, M. Vasakova,

. 2015 ; 15 (-) : 164. [pub] 20151221

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu klinická studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020078

Grantová podpora
NT14146 MZ0 CEP - Centrální evidence projektů

BACKGROUND: Biodegradable stents that disintegrate after a period of time are expected to be well tolerated and have advantages over other stents that are more commonly used in practice today. Polydioxanone is a biodegradable polymer that is widely used during surgery with absorbable sutures. METHODS: We present cases from the first four patients to undergo a tracheal polydioxanone stent insertion. Indications included significant non-malignant tracheal stenosis in cases where primary surgical treatment was not possible. The stents were implanted using rigid bronchoscopy and patients received regular follow-ups as needed. This use of biodegradable stents in adult patients was a novel, previously untested approach. The study was approved by the Institutional Ethics Committee and was based on a project entitled; "Biodegradable stents in the management of stenoses of large airways" (project NT 14146-3/2013). RESULTS: Six biodegradable stents were implanted in four patients with benign stenoses. No technical difficulties occurred and no serious or life-threatening events were recorded. All patients reported some benefit from treatment. CONCLUSION: Polydioxanone tracheal stents can be considered when a need for temporary support is expected, and as an alternative to other stents if the latter could compromise the patient. Owing to limited experience and observed disadvantages, further research is needed to fully assess this treatment. TRIAL REGISTRATION: This work is based on project NT14146 - Biodegradable stents in the management of stenoses of the large airways (2013-2015, MZ0/NT), registered from May 1, 2013 in The Research and Development and Innovation Information System of the Czech Republic and in ClinicalTrials.gov, reg. no. NCT02620319, December 2, 2015.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020078
003      
CZ-PrNML
005      
20191118123520.0
007      
ta
008      
160722s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12890-015-0160-6 $2 doi
024    7_
$a 10.1186/s12890-015-0160-6 $2 doi
035    __
$a (PubMed)26690793
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Stehlík, Luděk, $u Department of Respiratory Medicine, Charles University 1st Faculty of Medicine and Thomayer Hospital, Videnska 800, Prague 4, 140 59, Czech Republic. ludek.stehlik@ftn.cz. $d 1980- $7 xx0141866
245    10
$a Biodegradable polydioxanone stents in the treatment of adult patients with tracheal narrowing / $c L. Stehlik, V. Hytych, J. Letackova, P. Kubena, M. Vasakova,
520    9_
$a BACKGROUND: Biodegradable stents that disintegrate after a period of time are expected to be well tolerated and have advantages over other stents that are more commonly used in practice today. Polydioxanone is a biodegradable polymer that is widely used during surgery with absorbable sutures. METHODS: We present cases from the first four patients to undergo a tracheal polydioxanone stent insertion. Indications included significant non-malignant tracheal stenosis in cases where primary surgical treatment was not possible. The stents were implanted using rigid bronchoscopy and patients received regular follow-ups as needed. This use of biodegradable stents in adult patients was a novel, previously untested approach. The study was approved by the Institutional Ethics Committee and was based on a project entitled; "Biodegradable stents in the management of stenoses of large airways" (project NT 14146-3/2013). RESULTS: Six biodegradable stents were implanted in four patients with benign stenoses. No technical difficulties occurred and no serious or life-threatening events were recorded. All patients reported some benefit from treatment. CONCLUSION: Polydioxanone tracheal stents can be considered when a need for temporary support is expected, and as an alternative to other stents if the latter could compromise the patient. Owing to limited experience and observed disadvantages, further research is needed to fully assess this treatment. TRIAL REGISTRATION: This work is based on project NT14146 - Biodegradable stents in the management of stenoses of the large airways (2013-2015, MZ0/NT), registered from May 1, 2013 in The Research and Development and Innovation Information System of the Czech Republic and in ClinicalTrials.gov, reg. no. NCT02620319, December 2, 2015.
650    _2
$a senioři $7 D000368
650    _2
$a biokompatibilní materiály $x chemie $7 D001672
650    _2
$a bronchoskopie $7 D001999
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a polydioxanon $x chemie $7 D016687
650    _2
$a stenty $x klasifikace $7 D015607
650    _2
$a trachea $x chirurgie $7 D014132
650    _2
$a stenóza průdušnice $x chirurgie $7 D014135
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Česká republika $7 D018153
655    _2
$a klinická studie $7 D000068397
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hytych, Vladislav, $u Department of Thoracic Surgery, Thomayer Hospital, Videnska 800, Prague 4, 140 59, Czech Republic. vladislav.hytych@ftn.cz. $d 1954- $7 xx0077545
700    1_
$a Letackova, Jana $u ELLA-CS Ltd., Milady Horakove 504/45, Trebes, 500 06, Hradec Kralove, Czech Republic. jana.letackova@ellacs.eu.
700    1_
$a Kubena, Petr $u ELLA-CS Ltd., Milady Horakove 504/45, Trebes, 500 06, Hradec Kralove, Czech Republic. petr.kubena@ellacs.eu.
700    1_
$a Koziar Vašáková, Martina, $u Department of Respiratory Medicine, Charles University 1st Faculty of Medicine and Thomayer Hospital, Videnska 800, Prague 4, 140 59, Czech Republic. martina.vasakova@ftn.cz. $d 1964- $7 xx0104496
773    0_
$w MED00008206 $t BMC pulmonary medicine $x 1471-2466 $g Roč. 15, č. - (2015), s. 164
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26690793 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20191118123801 $b ABA008
999    __
$a ok $b bmc $g 1154748 $s 944606
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 15 $c - $d 164 $e 20151221 $i 1471-2466 $m BMC pulmonary medicine $n BMC Pulm Med $x MED00008206
GRA    __
$a NT14146 $p MZ0
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...